Results 131 to 140 of about 13,180,974 (307)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

ADMINISTRATIVE PROCEEDINGS AS A COMPONENT OF THE ADMINISTRATIVE PROCESS

open access: yesScientific Journal of Public and Private Law, 2023
openaire   +1 more source

Data Processing in University Administration [PDF]

open access: yesThe Computer Journal, 1960
P. F. Windley   +2 more
openaire   +1 more source

Improvement of Government Financing through Non-Conventional Methods: Reducing the Administrative Costs in the Public Sector [PDF]

open access: yes
The paper aims to emphasize the relative recent preoccupations of several European states and even of EU about reducing the administrative costs and contribution of this process to local and national development, increasing the GDP etc.
Dinu, Teodora, Matei, Ani
core  

Other title: Access Controls Policy 2100-11

open access: yes, 2020
[2020 update]; At head of title: DAS Policy; "Effective date: 10/10/2017."; Revision history: "10/10/2017: Original Policy; 8/17/2018, Reviewed policy and moved disabled account and self-service mechanism requirements to the now published DAS IT ...
Ohio. Department of Administrative Services
core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Other title: Security Assessment and Authorization Policy 2100-19

open access: yes, 2020
[06/10/2020 update]; At head of title: DAS Policy; "Effective date: 12/21/2018."; Policy number: 2100-19; "Revision history: 12/21/2018, Original Policy; 06/10/2020, Updated the policy template..."--Page 8; Includes bibliographical referencesThe purpose ...
Ohio. Department of Administrative Services
core  

Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology

open access: yesMolecular Oncology, EarlyView.
This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic   +15 more
wiley   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy